Browse result page of THPdb

The total number entries retrieved from this search are 31

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1098	ThPPIDTh1014	NameSalmon Calcitonin	Peptide SequenceCSNLSTCVLGKLSQELHKLQ Full view	Length32	Functional ClassificationIb	DiseaseOsteological	BrandCalcimar	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous or Intramuscular Injection	CategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents	TargetCalcitonin receptor
ID1099	ThPPIDTh1014	NameSalmon Calcitonin	Peptide SequenceCSNLSTCVLGKLSQELHKLQ Full view	Length32	Functional ClassificationIb	DiseaseOsteological	BrandFortical	CompanyN.A.	Physical AppearanceNasal spray	Route of AdministartionIntranasal use	CategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents	TargetCalcitonin receptor
ID1100	ThPPIDTh1014	NameSalmon Calcitonin	Peptide SequenceCSNLSTCVLGKLSQELHKLQ Full view	Length32	Functional ClassificationIb	DiseaseOsteological	BrandMiacalcin	CompanyNovartis	Physical AppearanceSolution	Route of AdministartionSubcutaneous or Intramuscular Injection	CategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents	TargetCalcitonin receptor
ID1205	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandHumulin R	CompanyEli Lilly and Company	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision.	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1206	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandNovolin R	CompanyNovo Nordisk	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1275	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog	CompanyEli Lilly	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1276	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog KwikPen	CompanyEli Lilly	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1277	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog Pen	CompanyEli Lilly	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1283	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus	CompanySanofi-Aventis	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1284	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus OptiSet	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1285	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus SoloStar	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1382	ThPPIDTh1060	NameInsulin, porcine	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	Brandvetsulin	CompanyIntervet Inc (Merck Animal Health)	Physical AppearanceSterile injectable suspension in multidose vials containing 10 mL of 40 IU/mL porcine insulin zinc suspension	Route of AdministartionSubcutaneous Injection	CategoryHypoglycemic Agents	TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Hyaluronan, Transforming growth factor beta-1
ID1462	ThPPIDTh1088	NameEnfuvirtide	Peptide SequenceYTSLIHSLIEESQNQQEKNE Full view	Length36	Functional ClassificationIIa	DiseaseInfectious	Brand`FUZEON	CompanyTrimeris, Roche	Physical AppearanceWhite to off-white, sterile, lyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryHIV Fusion Inhibitors	TargetOxytocin receptor,Oxytocin-neurophysin 1, Envelope glycoprotein
ID1478	ThPPIDTh1098	NameExenatide	Peptide SequenceHGEGTFTSDLSKQMEEEAVR Full view	Length39	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBYETTA	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryHypoglycemic Agents	TargetGlucagon-like peptide 1 receptor
ID1479	ThPPIDTh1098	NameExenatide	Peptide SequenceHGEGTFTSDLSKQMEEEAVR Full view	Length39	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBYDUREON	CompanyAmylin Pharmaceuticals	Physical AppearanceWhite to off-white powder that is available in a dosage strength of 2 mg exenatide per vial or per pen	Route of AdministartionN.A.	CategoryHypoglycemic Agents	TargetGlucagon-like peptide 1 receptor
ID1482	ThPPIDTh1100	NamePramlintide	Peptide SequenceKCNTATCATQRLANFLVHSS Full view	Length37	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandSymlin	CompanyAmylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)	Physical AppearanceClear, isotonic, sterile solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetCalcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3
ID1501	ThPPIDTh1104	NameCorticotropin	Peptide SequenceSYSMEHFRWGKPVGKKRRPV Full view	Length39	Functional ClassificationIV	DiseaseHormonal	BrandH.P. Acthar	CompanyQuestcor Pharmaceuticals, Inc.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryN.A.	TargetN.A.
ID1502	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog	CompanyNovo Nordisk	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous injection, Intravenous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1503	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 50/50	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1504	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 70/30	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart 100 Units/mL.	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1511	ThPPIDTh1106	NameInsulin Detemir	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandLEVEMIR	CompanyNovo Nordisk	Physical AppearanceClear, colorless, aqueous, neutral sterile solution	Route of AdministartionSubcutaneous injection	CategoryAntidiabetic Agents	TargetInsulin receptor
ID1520	ThPPIDTh1107	NameInsulin Glulisine	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandAPIDRA	Companysanofi-aventis	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionN.A.	CategoryAntidiabetic Agents	TargetInsulin receptor
ID1530	ThPPIDTh1109	NameNesiritide	Peptide SequenceSPKMVQGSGCFGRKMDRISS Full view	Length32	Functional ClassificationIb	DiseaseCardiac	BrandNATRECOR	CompanyScios unit of Johnson & Johnson,	Physical AppearanceWhite- to off-white lyophilized powder	Route of AdministartionIntravenous injection	CategoryN.A.	TargetN.A.
ID1534	ThPPIDTh1113	NameGlatiramer Acetate	Peptide SequenceEAYKAAEKAYAAKEAAKEAA Full view	Length52	Functional ClassificationIIa	DiseaseNeurological Disorder	BrandCopaxone	CompanyTeva Pharmaceutical Industries	Physical AppearanceClear, colorless to slightly yellow, sterile, nonpyrogenic solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetN.A.
ID1556	ThPPIDTh1120	NameTeriparatide	Peptide SequenceParathyroid hormone Full view	Length34	Functional ClassificationIb	DiseaseOsteological	BrandForteo	CompanyEli Lilly and Company	Physical AppearanceSterile, colorless, clear, isotonic solution	Route of AdministartionSubcutaneous injection	CategoryBone Density Conservation Agents	TargetParathyroid hormone/parathyroid hormone-related peptide receptor
ID1576	ThPPIDTh1124	NameLiraglutide	Peptide SequenceHAEGTFTSDVSSYLEGQAAK Full view	Length33	Functional ClassificationIb	DiseaseHormonal	BrandSaxenda	CompanyNovo Nordisk	Physical AppearanceClear, colorless solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 1 receptor
ID1577	ThPPIDTh1124	NameLiraglutide	Peptide SequenceHAEGTFTSDVSSYLEGQAAK Full view	Length33	Functional ClassificationIb	DiseaseHormonal	BrandVictoza	CompanyNovo Nordisk	Physical AppearanceClear, colorless solution.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 1 receptor
ID1603	ThPPIDTh1129	NameTesamorelin	Peptide SequenceYADAIFTNSYRKVLGQLSAR Full view	Length44	Functional ClassificationIb	DiseaseHormonal	BrandEgrifta	CompanyTheratechnologies	Physical AppearanceSterile, white to off-white, preservative-free lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGrowth hormone-releasing hormone receptor
ID1624	ThPPIDTh1137	NameTeduglutide	Peptide SequenceHGDGSFSDEMNTILDNLAAR Full view	Length33	Functional ClassificationIa	DiseaseMalabsorption disorder	BrandGattex	CompanyNPS Pharmaceuticals, Inc	Physical AppearanceClear, colorless to light-straw–colored liquid.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 2 receptor
ID1634	ThPPIDTh1140	NameInsulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn)	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovolin N	CompanyNovo Nordisk	Physical AppearanceNovolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe)	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1667	ThPPIDTh1158	NameAprotinin	Peptide SequenceRPDFCLEPPYTGPCKARIIR Full view	Length58	Functional ClassificationIIa	DiseaseImmunological	BrandTrasylol	CompanyBayer Pharmaceuticals	Physical AppearanceClear, colorless, sterile isotonic solution	Route of AdministartionIntravenous administration	CategoryN.A.	TargetTrypsin-1, Chymotrypsinogen B, Plasminogen, Kallikrein-!